Oncology Data Advisor
Cabozantinib/Atezolizumab for Metastatic Colorectal Cancer: Thomas Abrams, MD
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:05:52
- Mas informaciones
Informações:
Sinopsis
In this interview, Dr. Thomas Abrams of Harvard Medical School discusses the role that cabozantinib/atezolizumab may play for patients with metastatic colorectal cancer, particularly those with RAS wild-type disease, in the coming years.
